Basic General Checkup Package

US$467
NT$15,000 · you pay the hospital in NT$

Women: US$530 (NT$17,000). The price above is for men.

Without a Taiwan ID or NHI card: about US$561 (NT$18,000), 20% more by the hospital's own rules.

Book this checkup

Prefer to book it yourself? Call Cheng Hsin General Hospital on 02-28264400 ext. 3999 or use its English site ↗. It's free; most hospitals take bookings in Chinese.

We book it with the hospital for you, from US$149, paid only after the hospital confirms. We reply by email with available dates, the confirmed price, and whether an English report is available.

Paying from a US account? HSA and FSA notes.

Share on LINE / 分享到 LINE

As published by the hospital · checked 2026-09-22

A basic-tier program with Nasopharyngoscopy, Breast ultrasound, Pelvic (gynecologic) ultrasound, Creatine kinase and Resting ECG and a 62-test panel.

Takes
One day, no overnight
English report
Ask the hospital (we ask for you in Book it for me)

What stands out

Nasopharyngoscopy

Nasopharyngeal and throat abnormalities.

Breast ultrasound

Breast lumps; complements mammography, especially in dense breasts.

Pelvic (gynecologic) ultrasound

Uterus and ovary abnormalities (fibroids, cysts).

Creatine kinase

Muscle and heart muscle damage.

Every test, in English

62 tests listed, 42 of them on our shared test list, so they line up against other hospitals' packages.

Vitals1
Blood Count1
Liver Function7
Kidney & Electrolytes5
Lipids & Cardiometabolic5
Glucose2
Thyroid & Endocrine3
Tumor Markers7
Infection Serology3
Cardiac2
Ultrasound2
Endoscopy1
Women's Health1
Eye2
Show all 62 tests and what each screens for
TestScreens for
Vitals
Height, weight and BMIBasic body measurements used to assess weight-related health risk.
Blood Count
Iron studiesIron deficiency or iron overload.
Liver Function
AlbuminLiver function and nutrition status.
Alkaline phosphataseLiver, bile duct and bone conditions.
Direct bilirubinBile duct obstruction.
Gamma-GTBile duct and alcohol-related liver stress.
Globulin and A/G ratioImmune protein levels.
Total bilirubinJaundice, liver and bile problems.
Total proteinNutrition and liver/kidney protein handling.
Kidney & Electrolytes
Blood urea nitrogenKidney function.
CalciumBone, parathyroid and kidney conditions.
CreatinineKidney function.
Electrolytes (Na, K, Cl)Salt and fluid balance; kidney and hormone problems.
Uric acidGout risk and kidney stone risk.
Lipids & Cardiometabolic
HDL cholesterolProtective cholesterol level.
High-sensitivity CRPInflammation linked to heart disease risk.
LDL cholesterolThe main cholesterol driving heart disease risk.
Total cholesterolCardiovascular risk.
TriglyceridesCardiovascular and pancreatitis risk.
Glucose
Fasting glucoseDiabetes and prediabetes.
Hemoglobin A1cAverage blood sugar over the past three months; diabetes.
Thyroid & Endocrine
Free T4Thyroid hormone level.
TestosteroneMale hormone level; low testosterone.
TSHThyroid function; the primary thyroid screening test.
Tumor Markers
AFPLiver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA-125Ovarian cancer marker.
CA 15-3Breast cancer marker.
CA 19-9Pancreatic and biliary cancer marker.
CEAColorectal and other GI cancer marker.
CYFRA 21-1Lung cancer marker.
PSAProstate cancer marker.
Infection Serology
Hepatitis B surface antibodyImmunity to hepatitis B (from vaccine or past infection).
Hepatitis C antibodyHepatitis C infection.
Hepatitis B surface antigenCurrent hepatitis B infection; very common in Taiwan.
Cardiac
Creatine kinaseMuscle and heart muscle damage.
Resting ECGHeart rhythm and signs of prior heart damage.
Ultrasound
Breast ultrasoundBreast lumps; complements mammography, especially in dense breasts.
Pelvic (gynecologic) ultrasoundUterus and ovary abnormalities (fibroids, cysts).
Endoscopy
NasopharyngoscopyNasopharyngeal and throat abnormalities.
Women's Health
Pap smearCervical cancer and precancer.
Eye
Retinal (fundus) photographyDiabetic and hypertensive eye damage, macular degeneration.
Slit lamp examCataract and front-of-eye conditions.
Vitals
Height, weight and BMI
Basic body measurements used to assess weight-related health risk.
Blood Count
Iron studies
Iron deficiency or iron overload.
Liver Function
Albumin
Liver function and nutrition status.
Alkaline phosphatase
Liver, bile duct and bone conditions.
Direct bilirubin
Bile duct obstruction.
Gamma-GT
Bile duct and alcohol-related liver stress.
Globulin and A/G ratio
Immune protein levels.
Total bilirubin
Jaundice, liver and bile problems.
Total protein
Nutrition and liver/kidney protein handling.
Kidney & Electrolytes
Blood urea nitrogen
Kidney function.
Calcium
Bone, parathyroid and kidney conditions.
Creatinine
Kidney function.
Electrolytes (Na, K, Cl)
Salt and fluid balance; kidney and hormone problems.
Uric acid
Gout risk and kidney stone risk.
Lipids & Cardiometabolic
HDL cholesterol
Protective cholesterol level.
High-sensitivity CRP
Inflammation linked to heart disease risk.
LDL cholesterol
The main cholesterol driving heart disease risk.
Total cholesterol
Cardiovascular risk.
Triglycerides
Cardiovascular and pancreatitis risk.
Glucose
Fasting glucose
Diabetes and prediabetes.
Hemoglobin A1c
Average blood sugar over the past three months; diabetes.
Thyroid & Endocrine
Free T4
Thyroid hormone level.
Testosterone
Male hormone level; low testosterone.
TSH
Thyroid function; the primary thyroid screening test.
Tumor Markers
AFP
Liver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA-125
Ovarian cancer marker.
CA 15-3
Breast cancer marker.
CA 19-9
Pancreatic and biliary cancer marker.
CEA
Colorectal and other GI cancer marker.
CYFRA 21-1
Lung cancer marker.
PSA
Prostate cancer marker.
Infection Serology
Hepatitis B surface antibody
Immunity to hepatitis B (from vaccine or past infection).
Hepatitis C antibody
Hepatitis C infection.
Hepatitis B surface antigen
Current hepatitis B infection; very common in Taiwan.
Cardiac
Creatine kinase
Muscle and heart muscle damage.
Resting ECG
Heart rhythm and signs of prior heart damage.
Ultrasound
Breast ultrasound
Breast lumps; complements mammography, especially in dense breasts.
Pelvic (gynecologic) ultrasound
Uterus and ovary abnormalities (fibroids, cysts).
Endoscopy
Nasopharyngoscopy
Nasopharyngeal and throat abnormalities.
Women's Health
Pap smear
Cervical cancer and precancer.
Eye
Retinal (fundus) photography
Diabetic and hypertensive eye damage, macular degeneration.
Slit lamp exam
Cataract and front-of-eye conditions.
Also listed: ALT (SGPT), AST (SGOT), Abdominal X-ray, Chest X-ray (PA view), Chest X-ray (lateral view), Complete blood count (CBC), ENT consultation, Family medicine consultation, Fecal immunochemical test (FIT), Gynecology consultation, LDL/HDL ratio, Ophthalmology consultation, Prostate (ultrasound, men only), Thyroid (ultrasound), Total cholesterol/HDL ratio, Tuning fork hearing test, Urinalysis with microscopic sediment exam, Visual acuity, intraocular pressure and color vision, White blood cell differential, Zinc, male only.

Before you book

If something is foundAsk the hospital how any findings are explained, on the day or at a follow-up appointment; in Book it for me we ask for you and tell you before you book. Your own doctor decides what to do next; we do not arrange treatment.
Results and imagingAsk the hospital how long results take and how imaging is delivered; in Book it for me we ask for you and tell you before you book.
Cheng Hsin General Hospital Health Management Center
Regional hospital
Taipei · Beitou

About 10 minutes' walk (775 m) from Shipai station

On the OCAC i僑卡 partner list. Card holders can ask the center about a discount.

17 packages listed

About this hospital

What the center says

From the center's own pages, in English. Each statement links to its source.

Booking and payment
  • Payment for the checkup can be made by credit card or cash.

    Source ↗ · checked 2026-09-20

  • Visitors without an ROC ID card or NHI card are charged 1.2 times the local price under the hospital's international medical rules.

    Source ↗ · checked 2026-09-22

Results
  • Specialist physicians give patients an initial explanation of their checkup report on the same day.

    Source ↗ · checked 2026-09-20

  • Based on the patient's medical needs, the center can help refer them to the appropriate outpatient department when the report is explained.

    Source ↗ · checked 2026-09-20

US price context

Bought one by one at US cash-pay marketplaces, the tests we could price list at about US$2,589–2,925 for a woman (39 of 41 tests) and US$1,957–2,193 for a man (35 of 37 tests) (MDsave, Quest and others; checked 2026-10-11).

How we priced it

A panel counts once however many of its tests the package lists. A test for one sex only is counted only for that sex. Tests we could not price are left out, so this is not what a US checkup would cost. Prices marked "rough" come from a single reseller or are extrapolated from a similar test.

What US screening guidelines say

The US Preventive Services Task Force is an independent US panel whose recommendations cover people without symptoms. Shown for comparison; it is not advice for you.

What US screening guidelines say about 18 of these tests
Recommended (grade A/B)The USPSTF recommends screening all adults aged 18 to 79 years for hepatitis C virus infection. (2020) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of supplemental screening with breast ultrasound in women found to have dense breasts on an otherwise negative screening mammogram. (2024) · USPSTF ↗ Note: Same I statement covers ultrasound and MRI as supplemental tests; see mri_breast. The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with the CA-125 blood test. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers CA-125 and transvaginal/pelvic ultrasound; see pelvic_ultrasound.
Recommended against (grade D)The USPSTF recommends against screening for pancreatic cancer in asymptomatic average-risk adults. (2019) · USPSTF ↗ Note: The recommendation states there are currently no accurate, validated biomarkers for early detection of pancreatic cancer and that the USPSTF does not recommend screening the general population by any method; it does not name CA 19-9. The D grade applies to screening this population by any method, not to CA 19-9 as a separately graded test. It does not apply to people at high risk because of an inherited genetic syndrome or familial pancreatic cancer.
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a fasting plasma glucose test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for primary open-angle glaucoma in adults. (2022) · USPSTF ↗ Note: Same I-statement covers tonometry (intraocular pressure), optic-nerve/fundus imaging and OCT as candidate glaucoma-screening methods.
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a hemoglobin A1c test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Recommended (grade A/B)The USPSTF recommends screening for hepatitis B virus infection, with an HBsAg test followed by confirmatory testing, in adolescents and adults at increased risk for infection. (2020) · USPSTF ↗ Note: Risk groups include people born in a country with HBV prevalence of 2% or more, US-born people not vaccinated as infants whose parents were born in regions with very high HBV prevalence (8% or more), people with HIV, people who inject drugs, men who have sex with men, and household or sexual contacts of someone with HBV. The recommendation names regions by prevalence, not countries.
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Recommended (grade A/B)The USPSTF recommends that clinicians offer or refer adults with a body mass index of 30 or higher to intensive, multicomponent behavioral weight-loss interventions. (2018; an update is in progress) · USPSTF ↗ Note: The grade applies to offering or referring adults with a BMI of 30 or higher to intensive behavioral weight-loss programs, not to measuring height, weight or BMI; the USPSTF says screening for obesity is now part of routine clinical practice and was not a focus of its review. The USPSTF lists an update in progress, folded into a combined topic on healthy diet, physical activity and weight loss to prevent cardiovascular disease; the 2018 statement remains the current final recommendation as of 2026-09-25.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding high-sensitivity CRP to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF lists an update in progress for this statement, but the key questions in its research plan cover coronary artery calcium scoring only, not hs-CRP.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women younger than 21 years. (2018; an update is in progress) · USPSTF ↗
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (CIN 2 or 3) or cervical cancer. (2018; an update is in progress) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for cervical cancer every 3 years with cervical cytology alone in women aged 21 to 29 years. (2018; an update is in progress) · USPSTF ↗ Note: A draft update was posted December 10, 2024 (public comment to January 13, 2025); not yet a new final recommendation as of 2026-09-25.
Recommended (grade A/B)The USPSTF recommends screening for cervical cancer in women aged 30 to 65 years, every 3 years with cytology alone, every 5 years with high-risk HPV testing alone, or every 5 years with HPV testing combined with cytology. (2018; an update is in progress) · USPSTF ↗ Note: A draft update was posted December 10, 2024 (public comment to January 13, 2025); not yet a new final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women older than 65 years who have had adequate prior negative screening and are not otherwise at high risk. (2018; an update is in progress) · USPSTF ↗
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with transvaginal ultrasound. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers pelvic/transvaginal ultrasound and the CA-125 blood test; see ca125. This csv does not map pelvic_ultrasound to any recommendation about non-ovarian pelvic findings (fibroids, cysts), which the USPSTF does not address.
Selective (grade C)The USPSTF says the decision to undergo periodic PSA-based screening for prostate cancer should be an individual one for men aged 55 to 69 years. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against PSA-based screening for prostate cancer in men 70 years or older. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening with resting or exercise ECG to prevent cardiovascular disease events in asymptomatic adults at low risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening with resting or exercise ECG to prevent cardiovascular disease events in adults at intermediate or high risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for atrial fibrillation with ECG in adults 50 years or older. (2022) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
General preparation notes for 6 tests in this package

This is general information about how the exam is usually done, not medical advice for you or your family member. Requirements vary by center and by individual health history — always follow the center's own instructions and your own doctor's guidance, especially for any medicine change.

Total cholesterol

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested, so the test is often done in the morning.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Triglycerides

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Fasting glucose

Usually needs at least 8 hours without food or drink except water beforehand.

Mention when booking: If you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting, and mention it to the center.

Pelvic (gynecologic) ultrasound

For a transabdominal scan, drinking water beforehand to fill the bladder is common; for a transvaginal scan, an empty bladder is usual instead.

Mention when booking: Tell the center which type of scan you expect, and mention if you are, or might be, pregnant.

Pap smear

Usually asks that you avoid intercourse, douching and tampons for 24 hours beforehand, and avoid scheduling during your period if possible.

Mention when booking: Tell the center if you are having unexpected bleeding, think you might be pregnant, or have had an abnormal Pap or positive HPV test before.

Afterwards: Light bleeding or spotting afterward is common and usually stops within a few hours.

Retinal (fundus) photography

Often done with a camera that photographs the retina without drops; some centers use dilating drops that widen the pupil, which blurs vision for a few hours afterward.

Mention when booking: Mention any eye pain, halos around lights, or a narrow drainage angle or angle-closure glaucoma history.

Afterwards: If drops were used, vision may be blurry and light-sensitive for a few hours; have someone else drive. Sudden eye pain, headache, blurred vision or halos after dilation need urgent care.

Sources
As published by the hospital · checked 2026-09-22

How we collect and check these prices: see who we are and where the data comes from.

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.
Package name translated by us from the hospital's Chinese name.
Basic General Checkup Package
US$467
Book this checkup

If this isn't quite right

Other packages at Cheng Hsin General Hospital

PackageTestsPrice
Comprehensive Lab Testing Package G52
US$374
NT$12,000
+20% without Taiwan ID or NHI card
Entry-Level Cardiac Checkup Package48
US$467
NT$15,000
+20% without Taiwan ID or NHI card
Ultimate Lab Testing Package H65
US$498
NT$16,000
+20% without Taiwan ID or NHI card
Advanced Cardiac Checkup Package51
US$623
NT$20,000
+20% without Taiwan ID or NHI card
Standard General Checkup Package71
US$623
NT$20,000
Women US$685
+20% without Taiwan ID or NHI card
Elite General Checkup Package84
US$935
NT$30,000
Women US$997
+20% without Taiwan ID or NHI card
Senior Cardiac Checkup Package52
US$1,433
NT$46,000
+20% without Taiwan ID or NHI card
Enhanced Whole-Body MRI Cancer-Screening Checkup Package29
US$1,620
NT$52,000
Women from US$1,682
+20% without Taiwan ID or NHI card
Comprehensive Whole-Body MRI Cancer-Screening Checkup Package78
US$2,056
NT$66,000
Women from US$2,118
+20% without Taiwan ID or NHI card
Top-Tier Cardio-Cerebrovascular Checkup Package62
US$2,056
NT$66,000
+20% without Taiwan ID or NHI card

All packages at Cheng Hsin General Hospital Health Management Center →

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.

Browse: All checkups in Taipei · What a checkup costs in Taiwan